A detailed history of Ameriprise Financial Inc transactions in Geron Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 2,817,440 shares of GERN stock, worth $8.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,817,440
Previous 1,743,472 61.6%
Holding current value
$8.14 Million
Previous $7.39 Million 73.04%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $4.48 Million - $5.36 Million
1,073,968 Added 61.6%
2,817,440 $12.8 Million
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $3.34 Million - $5.48 Million
1,077,459 Added 161.78%
1,743,472 $7.39 Million
Q1 2024

May 15, 2024

BUY
$1.75 - $3.44 $85,137 - $167,356
48,650 Added 7.88%
666,013 $2.2 Million
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $23,075 - $30,635
13,262 Added 2.2%
617,363 $1.3 Million
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $344,153 - $534,987
163,106 Added 36.99%
604,101 $1.28 Million
Q2 2023

Aug 14, 2023

BUY
$1.97 - $3.69 $868,760 - $1.63 Million
440,995 New
440,995 $1.42 Million
Q1 2022

May 16, 2022

SELL
$0.99 - $1.6 $13,444 - $21,728
-13,580 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.22 - $1.72 $1,244 - $1,754
1,020 Added 8.12%
13,580 $17,000
Q3 2021

Nov 15, 2021

BUY
$1.2 - $1.5 $15,072 - $18,840
12,560 New
12,560 $17,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.09B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.